Journal Status & Publisher Information

International Journal of Clinical Innovation (IJCI) · www.ijcinnovation.org

Clinical Medicine, Clinical Research, Surgical Innovation, Medical Education, Outcomes Research, and Healthcare Innovation.

Target readership: Clinicians, surgeons, researchers, trainees, educators, methodologists, and healthcare professionals.

Publication language: English. IJCI publishes articles individually after final acceptance and production within an annual volume. Volume 1 corresponds to 2026. Exceptional production or integrity-review delays may occur and are communicated to affected authors when material.

International Journal of Clinical Innovation · Independent self-publisher · United States

Verified full mailing address: not yet published.

International Journal of Clinical Innovation (IJCI) is owned and independently self-published by Juan Pablo Dugarte. It is not an official publication of the University of Southern California or any other academic institution.

Editorial management is led by the Editor-in-Chief and the IJCI Editorial Board. Editorial decisions are governed by the journal's peer-review, publication-ethics, conflict-of-interest, and editorial-independence policies.

Institutional affiliations of editors are provided for identification purposes only. IJCI is an independent journal and is not an official publication of the University of Southern California.

Fully open access. Authors retain copyright. Published scholarly articles are licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) unless an article explicitly states otherwise.

IJCI does not charge manuscript submission fees, editorial processing fees, article processing charges (APCs), page charges, color charges, mandatory publication fees, or withdrawal fees.

Editorial decisions are based on scientific and editorial considerations and are independent of any current or future author fee, waiver, subsidy, donation, or sponsorship.

IJCI is independently self-published. Current journal operating costs are supported by the owner/publisher, with editorial and peer-review service contributed independently of any article-level payment.

Sponsors, donors, institutions, commercial partners, and other funders may not select reviewers, access confidential peer-review material, or influence editorial decisions. Any future journal-level sponsorship, donation, or unrestricted financial support will be disclosed publicly. Funding of individual research articles must be disclosed by authors in the published article.

IJCI does not currently accept paid advertising, advertorials, sponsored links, or commercially sponsored editorial content. If advertising is introduced in the future, it will be clearly identified and kept editorially separate from scholarly content and editorial decision-making.

Any direct marketing or recruitment conducted on behalf of IJCI, including manuscript, reviewer, or editorial-board invitations, must be accurate, appropriately targeted, professional, and unobtrusive. Communications must not promise acceptance, indexing, impact metrics, editorial appointment, or preferential treatment.

Published article metadata and publication assets are retained within IJCI's publication infrastructure. Corrections, retractions, and other post-publication notices are issued transparently and linked to the affected article rather than silently replacing the scholarly record.

IJCI is establishing independent long-term preservation with a recognized third-party preservation service. Until such participation is formally active, IJCI does not claim preservation through LOCKSS, CLOCKSS, Portico, PubMed Central, or another external archive.

Juan Pablo Dugarte
Editor-in-Chief and Publisher
editorial@ijcinnovation.org